Coline Arnould
Coline Arnould
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA USA
3Institute for Human Genetics, University of California, San Francisco, San Francisco, CA USA
1,2,3,#,
Vincent Rocher
Vincent Rocher
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,#,
Florian Saur
Florian Saur
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Aldo S Bader
Aldo S Bader
4Cancer Research UK Beatson Institute, Glasgow, UK
4,
Fernando Muzzopappa
Fernando Muzzopappa
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Sarah Collins
Sarah Collins
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Emma Lesage
Emma Lesage
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Benjamin Le Bozec
Benjamin Le Bozec
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Nadine Puget
Nadine Puget
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Thomas Clouaire
Thomas Clouaire
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Thomas Mangeat
Thomas Mangeat
5LITC Core Facility, Centre de Biologie Integrative, Université de Toulouse, CNRS, UPS, Toulouse, France
5,
Raphael Mourad
Raphael Mourad
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Nadav Ahituv
Nadav Ahituv
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA USA
3Institute for Human Genetics, University of California, San Francisco, San Francisco, CA USA
2,3,
Daan Noordermeer
Daan Noordermeer
6Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France
6,
Fabian Erdel
Fabian Erdel
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Martin Bushell
Martin Bushell
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA USA
7Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
2,7,
Aline Marnef
Aline Marnef
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,
Gaëlle Legube
Gaëlle Legube
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
1,✉
1MCD, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse, France
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA USA
3Institute for Human Genetics, University of California, San Francisco, San Francisco, CA USA
4Cancer Research UK Beatson Institute, Glasgow, UK
5LITC Core Facility, Centre de Biologie Integrative, Université de Toulouse, CNRS, UPS, Toulouse, France
6Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France
7Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Subject terms: Nuclear organization, DNA damage and repair
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.